Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
about
Anterior approach versus conventional liver resection for hepatocellular carcinomaCryotherapy for hepatocellular carcinomaEpidemiology of Hepatocellular Carcinoma in the Asia-Pacific RegionRole of supportive care for terminal stage hepatocellular carcinomaRisk factors for hepatocellular carcinoma in IndiaMolecular mechanisms underlying occult hepatitis B virus infection.Surveillance for hepatocellular carcinoma.Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variantsThe histone deacetylase inhibitor, Vorinostat, represses hypoxia inducible factor 1 alpha expression through translational inhibitionHepatocellular Carcinoma: Implications for Asia-Pacific Oncology NursesProgression of liver cirrhosis to HCC: an application of hidden Markov model.Hepatocellular carcinoma: clinicopathological profile and challenges of management in a resource-limited setting.Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma.First multicenter study for risk factors for hepatocellular carcinoma development in North Africa.The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.Hepatobiliary quiz-12 (2014).Cirrhosis and Chronic Viral Hepatitis as Risk Factors for Hepatocellular Carcinoma: Romanian Single-clinic Experience.Epidemiology of hepatitis C: related hepatocellular carcinoma in CameroonViral genotypes and associated risk factors of hepatocellular carcinoma in India.Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors.Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI gradeDownregulation of microRNA-132 indicates progression in hepatocellular carcinoma.Tackling hepatitis B virus-associated hepatocellular carcinoma--the future is now.Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives.Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.Hepatitis virus and hepatocellular carcinoma in Brazil: a report from the State of Espírito Santo.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.A long-term follow-up and comprehensive observation of risk and prognosis factors of recurrence and survival after resection of hepatocellular carcinoma.Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India.Risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.Genetic variants of heat shock protein A1L2437 and A1B1267 as possible risk factors for hepatocellular carcinoma in India.Recognition criteria for occupational cancers in relation to hepatitis B virus and hepatitis C virus in Korea.Plasma levels of matrix metalloproteinase-2 and -9 in male and female patients with cirrhosis of different aetiologies.Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma.
P2860
Q24202980-2442968F-E1C3-4DBA-943C-9E50D5925050Q24240225-736E26CA-C95D-4FD5-B0F8-A5EFA461294FQ26750444-D03C99ED-07A0-43B8-AF03-7936548F9CD1Q26822263-E93DFF98-E18D-4392-8C2F-8F5BE8962254Q26830794-510A5163-7B9B-4C7B-9542-533B4E753FFEQ27686923-C90BC2E3-7228-4B3E-AB1C-D9975FFC4EA6Q27690269-F35CF08F-807C-4DFE-8DBC-7E1A5D0F96EEQ28482260-E88D1794-5A51-4F1B-AC98-903DA032E3FBQ28542639-2331B999-6C94-4C69-92C4-AA00A2DEE848Q30234460-CFC3C003-3212-4266-A9B3-6D7FE55C4863Q33860546-3836207B-C3CF-4875-846B-5256537544ABQ34000108-A06F8913-98AB-47CC-98F0-5130C48CD70DQ34297798-2D4B8382-0753-4D5B-ABF3-133DB738B668Q34560817-EDD64589-0FFD-4641-87F0-DF10A97782DBQ34826535-40969149-40CC-43A4-ADC6-99B983EB6D2FQ34983479-5DBF9346-9155-4830-8CF6-25A3A40E1E4AQ35154758-80E9388A-6899-430F-9651-0D00C79A3257Q35593576-55BDEDE7-50C6-48B6-BB68-D3920E955AF0Q36814387-32217914-67EA-4185-8C93-E36820F77F23Q37087484-2875ACA1-F717-47D3-B7C7-9121B3C07EC1Q37174913-219C36C9-6C4B-469C-87DA-C1D969419AB2Q37288584-CB2F2BC5-F696-41A2-8E28-C80162B8CD62Q38056849-206CDEBF-0B21-44C0-9E1B-41757E15D399Q39063034-09D24836-ACEE-4AE7-95C1-CCF186C32178Q39218547-D7BB1B90-EAFB-4DB7-B9E1-BE4DEFB28DF9Q41623025-57C68688-5DC6-4AFE-845E-45D586F2EF39Q41962614-CB75871E-0047-4664-871D-9EEC3EDC0158Q42224788-B104CD43-AF4D-41F5-85F7-3097CA02134FQ42256081-9716328D-A1CA-49F1-8656-71D8EC40F05BQ43185894-9B5F0273-1363-4D32-9FD5-D88E86F0E3BAQ43676819-E982BC7A-DF62-408B-9FD4-06FC86FE355EQ48501525-92F3B6BC-375C-4CEE-940F-4A732C0D4109Q50998028-81361D7E-2C82-4612-ABA9-D65211CD05B5Q51748031-72B33F85-01A6-4D72-9483-B09967D9D694
P2860
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Risk factors analysis for hepa ...... carcinoma patients from India.
@en
Risk factors analysis for hepa ...... carcinoma patients from India.
@nl
type
label
Risk factors analysis for hepa ...... carcinoma patients from India.
@en
Risk factors analysis for hepa ...... carcinoma patients from India.
@nl
prefLabel
Risk factors analysis for hepa ...... carcinoma patients from India.
@en
Risk factors analysis for hepa ...... carcinoma patients from India.
@nl
P2093
P2860
P921
P1476
Risk factors analysis for hepa ...... carcinoma patients from India.
@en
P2093
Barjesh Chander Sharma
Manoj Kumar Saraswat
Manoj Kumar
Puja Sakhuja
Rakesh Kumar
Shiv Kumar Sarin
Syed S Hissar
P2860
P304
P356
10.1111/J.1440-1746.2007.04908.X
P577
2007-06-07T00:00:00Z